Acurx Pharmaceuticals (ACXP) Insider Trading & Ownership $0.88 +0.10 (+12.20%) As of 01/17/2025 04:00 PM Eastern Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Acurx Pharmaceuticals (NASDAQ:ACXP) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage29.60%Number OfInsiders Buying(Last 12 Months)2Amount OfInsider Buying(Last 12 Months)$74,630.92Number OfInsiders Selling(Last 12 Months)0 Get ACXP Insider Trade Alerts Want to know when executives and insiders are buying or selling Acurx Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address ACXP Insider Buying and Selling by Quarter Acurx Pharmaceuticals Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails1/6/2025David P LuciCEOBuy49,261$1.01$49,753.61 1/6/2025Joseph C ScodariDirectorBuy24,631$1.01$24,877.31 (Data available from 1/1/2013 forward) ACXP Insider Trading Activity - Frequently Asked Questions Who is on Acurx Pharmaceuticals's Insider Roster? The list of insiders at Acurx Pharmaceuticals includes Carl Sailer, David P Luci, and Joseph C Scodari. Learn more on insiders at ACXP. What percentage of Acurx Pharmaceuticals stock is owned by insiders? 29.60% of Acurx Pharmaceuticals stock is owned by insiders. Learn more on ACXP's insider holdings. Which Acurx Pharmaceuticals insiders have been buying company stock? The following insiders have purchased ACXP shares in the last 24 months: David P Luci ($49,753.61), and Joseph C Scodari ($24,877.31). How much insider buying is happening at Acurx Pharmaceuticals? Insiders have purchased a total of 73,892 ACXP shares in the last 24 months for a total of $74,630.92 bought. Acurx Pharmaceuticals Key ExecutivesMr. Robert J. DeLuccia (Age 78)Co-Founder & Executive Chairman Compensation: $701.54kMr. David P. Luci CPA (Age 57)Esq., J.D., Co-Founder, President, CEO, Corporate Secretary & Director Compensation: $668.98k1 recent tradesMr. Robert G. Shawah CPA (Age 57)CPA, Co-Founder & CFO Compensation: $470.29k More Insider Trading Tools from MarketBeat Related Companies Elevation Oncology Insider Trades Tonix Pharmaceuticals Insider Trades Invivyd Insider Trades Xilio Therapeutics Insider Trades Kezar Life Sciences Insider Trades ImmuCell Insider Trades VYNE Therapeutics Insider Trades Celularity Insider Trades Aileron Therapeutics Insider Trades Nabriva Therapeutics Insider Trades Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles 3 Stocks With Strong Capital Returns and Insider Buying SignalsZymeworks in Focus for Insider Activity: Catalysts AheadInsiders Are Loading Up: 3 Key Stock Picks for InvestorsInsiders Are Selling, But These 3 Stocks Are Must-Buys3 Stocks That Wall Street Insiders Can’t Stop Buying This page (NASDAQ:ACXP) was last updated on 1/18/2025 by MarketBeat.com Staff From Our PartnersURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredDo this Before Elon’s Reveal on January 22ndElon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but...Brownstone Research | Sponsoredliberals FOOLED by Elon’s shocking surpriseElon Musk and Donald Trump fooled everyone. They said it was to “save free speech”... Or “fix what the l...StocksToTrade | SponsoredStunning Trump Exec Order LeakedThis secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | SponsoredThe Biggest Money-Making Idea in My 43 Years in the Stock MarketBillionaires and top investors - including the late great Charlie Munger - and many more names you would recog...The Oxford Club | SponsoredGrab This Altcoin Before Trump's Crypto AnnouncementThe #1 Coin Poised to Soar Under Trump Pro-Crypto White House could make this the investment opportunity of...Crypto 101 Media | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Acurx Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Acurx Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ACXP Stock Alerts